| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/11/2023 | 32.36% | HC Wainwright & Co. | $17 → $20 | Maintains | Buy |
| 08/01/2023 | 12.51% | HC Wainwright & Co. | → $17 | Reiterates | Buy → Buy |
| 06/30/2023 | 78.69% | Wedbush | → $27 | Initiates Coverage On | → Outperform |
| 05/08/2023 | 65.45% | Oppenheimer | → $25 | Reiterates | → Outperform |
| 05/05/2023 | 12.51% | HC Wainwright & Co. | → $17 | Reiterates | → Buy |
| 03/23/2023 | 12.51% | HC Wainwright & Co. | → $17 | Reiterates | → Buy |
| 03/07/2023 | 12.51% | HC Wainwright & Co. | $15 → $17 | Maintains | Buy |
| 03/02/2023 | -0.73% | HC Wainwright & Co. | $12 → $15 | Maintains | Buy |
| 02/03/2023 | 12.51% | Oppenheimer | → $17 | Initiates Coverage On | → Outperform |
| 06/23/2022 | -20.58% | HC Wainwright & Co. | → $12 | Initiates Coverage On | → Buy |
| 03/08/2022 | 78.69% | Jefferies | $31 → $27 | Upgrades | Hold → Buy |
| 11/08/2021 | 105.16% | Jefferies | $19 → $31 | Downgrades | Buy → Hold |
| 10/11/2021 | 45.6% | B of A Securities | → $22 | Initiates Coverage On | → Buy |
| 10/11/2021 | 25.74% | Jefferies | → $19 | Initiates Coverage On | → Buy |
| 10/11/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform |
What is the target price for Tyra Biosciences (TYRA)?
The latest price target for Tyra Biosciences (NASDAQ: TYRA) was reported by HC Wainwright & Co. on August 11, 2023. The analyst firm set a price target for $20.00 expecting TYRA to rise to within 12 months (a possible 32.36% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Tyra Biosciences (TYRA)?
The latest analyst rating for Tyra Biosciences (NASDAQ: TYRA) was provided by HC Wainwright & Co., and Tyra Biosciences maintained their buy rating.
When is the next analyst rating going to be posted or updated for Tyra Biosciences (TYRA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tyra Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tyra Biosciences was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
Is the Analyst Rating Tyra Biosciences (TYRA) correct?
While ratings are subjective and will change, the latest Tyra Biosciences (TYRA) rating was a maintained with a price target of $17.00 to $20.00. The current price Tyra Biosciences (TYRA) is trading at is $15.11, which is out of the analyst's predicted range.